Stan Smith
Director · MAIA Biotechnology, Inc.
IndividualBuying only
- 2024
- Oct 2, 2026
- 15
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Stan Smith files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Vlad Vitoc - $302K in MAIA purchases and sales in the last 12 months
- Ramiro Guerrero - $252K in MAIA purchases and sales in the last 12 months
- Ngar Yee Louie - $211K in MAIA purchases and sales in the last 12 months
- Steven M. Chaouki - $106K in MAIA purchases and sales in the last 12 months
- Cristian Luput - $52K in MAIA purchases and sales in the last 12 months
- Sergei Gryaznov - $3K in MAIA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stan Smith?
Stan Smith is a corporate insider, tracked as Director of MAIA Biotechnology, Inc. (MAIA). InsiderAlpha holds 15 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Stan Smith submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Stan Smith been buying or selling stock?
Recorded transactions: 13 open-market purchases ($929K) and 0 open-market sales across all tracked filings.
